Subsequently, we introduce the clinical research on inhibition of sEH for regulation of renal-associated diseases, including acute kidney injury, chronic kidney diseases, diabetic nephropathy and hypertension-induced renal injury. Here, EPHX2 is linked to acute kidney injury.